Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00592137
Other study ID # DK66108 (completed)
Secondary ID 5R01DK066108
Status Completed
Phase N/A
First received December 26, 2007
Last updated January 12, 2010
Start date April 2004
Est. completion date August 2004

Study information

Verified date January 2010
Source National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Lifestyle choices,including diet,are conducive to healthy body weights in children. Dairy products and calcium supplementation have been associated with moderation of body weight and body fat. This study was designed to test the following hypotheses with overweight and obese adolescents consuming a controlled diet:

- Dietary calcium supplementation as calcium carbonate or dairy calcium modulates energy balance in adolescents.

- Increased calcium in the diet of adolescents will increase fecal fat excretion and thereby decrease fat absorption.

- Calcium and dairy product supplementation will increase lipid oxidation resulting in an increase in energy expenditure.


Description:

Subjects will consume a controlled diet containing 800 mg calcium for two three week periods. During one period they will also receive a frozen ice cream like product (smoothie) twice a day based on soy protein that contains no additional calcium. During the other period they will receive a similar product twice a day based on either dairy protein that contains 650 mg calcium or based on soy protein that contains 650 mg calcium as calcium carbonate


Recruitment information / eligibility

Status Completed
Enrollment 43
Est. completion date August 2004
Est. primary completion date August 2004
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 15 Years
Eligibility Inclusion Criteria:

- Over weight (>85th percentile BMI for age)

Exclusion Criteria:

- > 180% of ideal body weight for height

- Malabsorptive disorders

- Bone disease

- Liver disease

- Kidney disease

- Anemia

- Smoking or illegal drugs

- Oral contraceptives

- Pregnancy

- Medications that influence calcium metabolism

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
C (smoothies based on soy protein containing no additional calcium)
Two smoothies per day based on soy protein containing no additional calcium
B (smoothies based on soy protein containing calcium)
Two smoothies daily based on soy protein containing 650 mg calcium as calcium carbonate
A (smoothies based on dairy protein containing calcium)
Two smoothies daily based on dairy protein containing 650 mg calcium

Locations

Country Name City State
United States Department of Foods and Nutrition W. Lafayette Indiana

Sponsors (2)

Lead Sponsor Collaborator
Purdue University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Energy balance will be calculated by quantitating the kilocalories represented by the following components: dietary intake, excreta, physical activity, resting energy expenditure, thermic effect of food, and thermogenesis. After equilibration on a controlled diet for one week, measurements will be taken over an additional two week period. No
Secondary Serum biochemical measures of calcium metabolism (PTH, Vitamin D, and calcium) Serial meausures over a 10 hour period following a meal containing calcium from the placebo, dairy or calcium carbonate supplement No
Secondary Calcium retention Two weeks on a controlled diet following one week of equilibration on the same diet No
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2